81 FR 45504 - National Institute for Occupational Safety and Health (NIOSH), Safety and Occupational Health Study Section: Notice of Charter Renewal

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 135 (July 14, 2016)

Page Range		45504-45504
FR Document		2016-16583

Federal Register, Volume 81 Issue 135 (Thursday, July 14, 2016)

[Federal Register Volume 81, Number 135 (Thursday, July 14, 2016)]
[Notices]
[Page 45504]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-16583]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Institute for Occupational Safety and Health (NIOSH), 
Safety and Occupational Health Study Section: Notice of Charter Renewal

    This gives notice under the Federal Advisory Committee Act (Pub. L. 
92-463) of October 6, 1972, that the Safety and Occupational Health 
Study Section, Centers for Disease Control and Prevention, Department 
of Health and Human Services, has been renewed for a 2-year period 
through June 30, 2018.
    For more information contact: JoAnne Fairbanks, Executive 
Secretary, Safety and Occupational Health Study Section, Department of 
Health and Human Services, 1600 Clifton Road NE., Mailstop E74, 
Atlanta, Georgia 30333, telephone 304/285-6143 or fax 304/285-6147.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2016-16583 Filed 7-13-16; 8:45 am]
BILLING CODE 4163-18-P

45504 Federal Register / Vol. 81, No. 135 / Thursday, July 14, 2016 / Notices

iii. Hyaluronic acid (to be assessed for individuals with OA in one knee DEPARTMENT OF HEALTH AND
review in next update) are likely to have some, but not HUMAN SERVICES
C. Topical and transdermal agents (to necessarily identically, reduced
be assessed for review in next function in the other knee and that Centers for Disease Control and
update) treatment of one knee only may Prevention
i. Capsaicin (to be assessed for review improve pain in that knee but may
in next update) not markedly improve function National Institute for Occupational
ii. NSAIDs (to be assessed for review VIII. Studies that use participants as Safety and Health (NIOSH), Safety and
in next update) their own controls will be excluded, Occupational Health Study Section:
II. Cell-based therapies unless no randomized controlled Notice of Charter Renewal
A. Platelet-rich plasma trials are identified for a particular This gives notice under the Federal
B. Intraarticular or arthroscopic intervention of interest, as quasi- Advisory Committee Act (Pub. L. 92–
administration of mesenchymal experimental designs provide 463) of October 6, 1972, that the Safety
stem-cells or chondrocytes or tissue weaker evidence. and Occupational Health Study Section,
C. Exclusions: IX. Exclusions: Centers for Disease Control and
i. Phase I or II trials will not be A. Studies that use an active control Prevention, Department of Health and
included for efficacy, as the that has not been established to be Human Services, has been renewed for
interventions are generally not effective will be excluded. Efficacy a 2-year period through June 30, 2018.
FDA-approved for use. and effectiveness must be For more information contact: JoAnne
III. Physical treatments and/or weight established before examining Fairbanks, Executive Secretary, Safety
loss comparative effectiveness and Occupational Health Study Section,
A. Physical therapy and exercise questions. Department of Health and Human
programs Services, 1600 Clifton Road NE.,
i. Manual therapy Outcomes Mailstop E74, Atlanta, Georgia 30333,
ii. Land-based therapy and/or exercise I. Short-term clinical outcomes telephone 304/285–6143 or fax 304/
iii. Exercise programs (aerobic, A. Pain (e.g., VAS, WOMAC, KOOS,) 285–6147.
resistance) B. Joint stiffness (WOMAC) The Director, Management Analysis
iv. Aquatherapy C. Function (WOMAC, Lequesne, and Services Office, has been delegated
v. Balneotherapy, mud therapy the authority to sign Federal Register
others)
vi. Heat or cold notices pertaining to announcements of
D. OARSI physical outcomes (e.g.,
vii. Self-management programs meetings and other committee
B. Weight loss timed up-and-go, 6-minute walk
test) management activities, for both the
C. Braces or kinesiology taping Centers for Disease Control and
D. Orthotic shoe inserts and/or E. Patient Reported Outcome
Measurement System (PROMIS®) Prevention and the Agency for Toxic
wedges Substances and Disease Registry.
E. Vibrating platform and Osteoarthritis-Computer
F. Neuromuscular electrical Adaptive Test (OA–CAT) Catherine Ramadei,
stimulation (e.g., Transcutaneous F. Inflammation or effusion Acting Director, Management Analysis and
electrical nerve stimulation) G. Medication use Services Office, Centers for Disease Control
IV. Acupuncture (to be assessed for II. Long-term clinical outcomes and Prevention.
review in next update) A. Any of the short-term clinical [FR Doc. 2016–16583 Filed 7–13–16; 8:45 am]
A. Needle acupuncture alone (to be outcomes BILLING CODE 4163–18–P
assessed for review in next update) B. Instrumental activities of daily
B. Moxibustion (to be assessed for living (IADLs)
review in next update) C. Quality of life (e.g., SF–36, DEPARTMENT OF HEALTH AND
V. Combination interventions (to be EuroQuol EQ–5D, Arthritis Self- HUMAN SERVICES
assessed for review in next update) Efficacy scale, global assessment,
A. Sequential treatment algorithms (to patient satisfaction) Centers for Disease Control and
be assessed for review in next D. Surgery (i.e., rate of undergoing Prevention
update) knee replacement) National Institute for Occupational
III. Adverse effects of intervention(s) Safety and Health (NIOSH), Advisory
Comparators
IV. Outcome reporting Board on Radiation and Worker Health
I. Pharmacologic treatments: Placebo- A. Only studies that report outcomes (ABRWH or Advisory Board)
controlled or head-to-head non- for knee OA alone
inferiority only B. Mean differences at followup or In accordance with section 10(a)(2) of
II. Cell-based therapies: Placebo- or percent of responders at followup the Federal Advisory Committee Act
sham-controlled only will be abstracted (Pub. L. 92–463), and pursuant to the
III. Physical treatments and/or weight requirements of 42 CFR 83.15(a), the
loss: Placebo-controlled, usual care- Timing Centers for Disease Control and
controlled, or wait list-controlled Minimum 1 month follow-up from Prevention (CDC), announces the
only except for weight loss
asabaliauskas on DSK3SPTVN1PROD with NOTICES

initiation of treatment following meeting of the
IV. Neuromuscular electrical aforementioned committee:
stimulation: Sham stimulation Settings Times and Dates: 8:15 a.m.–5:00 p.m.,
without current Any setting Mountain Time, August 9, 2016; 8:15
V. Wait list a.m.–1:00 p.m., Mountain Time, August
VI. Treatment as usual Andrew B. Bindman, 10, 2016.
VII. Studies that use the untreated knee AHRQ Director. Public Comment Time and Date: 5:00
as a control will be excluded, based [FR Doc. 2016–16632 Filed 7–13–16; 8:45 am] p.m.–6:00 p.m.*, Mountain Time,
on evidence indicating that BILLING CODE 4160–90–P August 9, 2016.

VerDate Sep<11>2014 19:33 Jul 13, 2016 Jkt 238001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\14JYN1.SGM 14JYN1

Document Created: 2016-07-14 01:54:42
Document Modified: 2016-07-14 01:54:42

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		81 FR 45504

81 FR 45504 - National Institute for Occupational Safety and Health (NIOSH), Safety and Occupational Health Study Section: Notice of Charter Renewal

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 81, Issue 135 (July 14, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention